Categorized | Prostate Health

Prostate Growth Not Affected by DHT

According to the study finding published in the Annals of Internal Medicine, daily use of transdermal dihydrotestosterone (DHT) treatment over two years had no beneficial effect on prostate growth but was associated with a reduction in spinal bone mineral density (BMD) .

In the study 114 men aged 50 years and older with no known prostate disease received the hormone therapy or placebo for 2 years to determine whether long-term administration of a nonamplifiable pure androgen would reduce prostate growth.  The result – in all men, over  time average prostate size increased with total prostate volume growing by 29% and central prostate volume by 75% with a 15% hike in serum PSA level.

Comments are closed.